Bright Minds Biosciences (DRUG) Change in Receivables (2024 - 2025)
Bright Minds Biosciences (DRUG) reported Change in Receivables of -$42340.4 for Q4 2025, down 243.14% on a YoY basis from $29580.3 in Q4 2024, and down 243.14% quarter-over-quarter from $29580.3 in Q4 2024.
Bright Minds Biosciences (DRUG) Change in Receivables (2024 - 2025) Analysis & Trends
Bright Minds Biosciences has reported Change in Receivables for 2 years, with the latest figure at -$42340.4 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -4.08 Mn |
| 10 | Bright Minds Biosciences | 18.30 Bn | 18.24 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42,340.36 |
| Dec 31, 2025 | -42,340.36 |
| Dec 31, 2024 | 29,580.32 |
| Dec 31, 2024 | 29,580.32 |